We would like to thank Ridola et al. for their interest in our recently published article.
[1]
,[2]
Our study of 754 outpatients with cirrhosis, demonstrated that ammonia was an independent
predictor of mortality and when expressed as a ratio of the local laboratory upper
limit of normal (AMM-ULN), >1.4 defines a high-risk group for the development of liver-related
complications. This was confirmed in an independent validation cohort of 130 stable
outpatients with cirrhosis.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of HepatologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis.J Hepatol. 2022; (online ahead of print)
- Ammonia and prognosis of cirrhosis: a new perspective for identifying high risk patients.J Hepatol. 2022; (online ahead of print)
- Arterial ammonia levels in cirrhosis are determined by systemic and hepatic hemodynamics, and by organ function: a quantitative modelling study.Liver Int. 2014 Jul; 34: e45-e55
Article info
Publication history
Published online: November 02, 2022
Accepted:
October 20,
2022
Received:
October 17,
2022
Footnotes
Author names in bold designate shared co-first authorship
Identification
Copyright
© 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
